Ad is loading...
APGE
Price
$44.01
Change
+$1.15 (+2.68%)
Updated
Nov 22, 03:15 PM (EDT)
SRRK
Price
$26.67
Change
-$1.19 (-4.27%)
Updated
Nov 21 closing price
109 days until earnings call
Ad is loading...

APGE vs SRRK

Header iconAPGE vs SRRK Comparison
Open Charts APGE vs SRRKBanner chart's image
Apogee Therapeutics
Price$44.01
Change+$1.15 (+2.68%)
Volume$200
CapitalizationN/A
Scholar Rock Holding
Price$26.67
Change-$1.19 (-4.27%)
Volume$818.93K
CapitalizationN/A
APGE vs SRRK Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
APGE vs. SRRK commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and SRRK is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (APGE: $42.86 vs. SRRK: $26.67)
Brand notoriety: APGE and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 113% vs. SRRK: 35%
Market capitalization -- APGE: $2.56B vs. SRRK: $2.61B
APGE [@Biotechnology] is valued at $2.56B. SRRK’s [@Biotechnology] market capitalization is $2.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 6 bearish.
  • SRRK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -15.97% price change this week, while SRRK (@Biotechnology) price change was -3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.09%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.96%.

Reported Earning Dates

APGE is expected to report earnings on Nov 13, 2024.

SRRK is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+2.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($2.61B) and APGE($2.56B) have the same market capitalization . APGE YTD gains are higher at: 53.400 vs. SRRK (41.862). APGE has higher annual earnings (EBITDA): -169.13M vs. SRRK (-228.52M). APGE has more cash in the bank: 526M vs. SRRK (139M). APGE has less debt than SRRK: APGE (12.1M) vs SRRK (66.6M). APGE (0) and SRRK (0) have equivalent revenues.
APGESRRKAPGE / SRRK
Capitalization2.56B2.61B98%
EBITDA-169.13M-228.52M74%
Gain YTD53.40041.862128%
P/E RatioN/AN/A-
Revenue00-
Total Cash526M139M378%
Total Debt12.1M66.6M18%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGESRRK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSNYX35.890.69
+1.96%
Victory Global Energy Transition Y
TEPSX31.530.47
+1.51%
ProFunds Technology UltraSector Svc
MTISX20.810.16
+0.77%
NYLI Income Builder SIMPLE Class
TRBCX200.740.10
+0.05%
T. Rowe Price Blue Chip Growth
JAOSX45.44-0.04
-0.09%
Janus Henderson Overseas T

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with ACLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-4.84%
ACLX - APGE
41%
Loosely correlated
N/A
BHVN - APGE
40%
Loosely correlated
-3.50%
SYRE - APGE
39%
Loosely correlated
-1.82%
ALLO - APGE
38%
Loosely correlated
+2.93%
SRRK - APGE
34%
Loosely correlated
-4.27%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-4.27%
ORMP - SRRK
42%
Loosely correlated
+2.21%
PLRX - SRRK
41%
Loosely correlated
+0.94%
VTGN - SRRK
40%
Loosely correlated
-3.07%
SNDX - SRRK
39%
Loosely correlated
-2.19%
ONCY - SRRK
38%
Loosely correlated
-1.85%
More